| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.49 | 9e-14 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.38 | 6e-10 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-08 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-08 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.34 | 7e-08 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.36 | 1e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-07 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.33 | 5e-07 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-06 |